GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » Selling and Marketing Expense

Medartis Holding AG (XSWX:MED) Selling and Marketing Expense : CHF97.5 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Medartis Holding AG Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Medartis Holding AG's Selling and Marketing Expense for the six months ended in Dec. 2023 was CHF49.2 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF97.5 Mil.

Medartis Holding AG Selling and Marketing Expense Historical Data

The historical data trend for Medartis Holding AG's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medartis Holding AG Selling and Marketing Expense Chart

Medartis Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.91 65.47 77.09 94.34 97.51

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.03 44.16 50.18 48.28 49.23

Medartis Holding AG Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF97.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Medartis Holding AG's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medartis Holding AG (XSWX:MED) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » Selling and Marketing Expense
Comparable Companies
XSWX:KURN XSWX:MOVE ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN. PODD OCSE:DEMANT BRKR
Traded in Other Exchanges
MEDz:UK
Address
Hochbergerstrasse 60E, Basel, CHE, 4057
Website
https://www.medartis.com
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for Cranium, Midface, and mandible. Geographically, it derives majority of the revenue from EMEA and also has a presence in APAC; LATAM and North America.